3 days ago
Pharma M&A in Action: Explore Our Solutions for Target Screening & Valuation
In today's fast-evolving pharmaceutical industry, mergers and acquisitions are critical for companies looking to expand into new areas, strengthen their portfolios, and drive innovation. But how do you identify the right opportunities and ensure a strategic fit?
Join our exclusive webinar to see how Bloomberg's powerful data and analytics can streamline your M&A workflow—from initial target screening to deal benchmarking and valuation.
We'll cover:
How to identify and screen high-potential acquisition targets
Competitive landscape analysis for strategic decision-making
Benchmarking deals & assessing valuations with our tools
Note: We're pleased to share that AI live captions will be available in multiple languages.
※日本語字幕有（機械翻訳）
Speakers
Kumar Ramamurthy
Healthcare Industry Specialist
Bloomberg
Kumar is a Healthcare Industry Specialist supporting Bloomberg's Corporations initiative where he covers Pharma companies within their M&A/Strategy/Corp Dev teams. He joined Bloomberg a year ago. Prior to joining Bloomberg, he spent 8 years in Investment Banking covering Healthcare M&A. He has worked in the M&A Teams at Morgan Stanley and UBS in London having served as an advisor on M&A deals, IPO/Capital Raise/Private Funding rounds as well as Defense Mandates.
